Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890924006> ?p ?o ?g. }
- W2890924006 abstract "Besides understanding the effectiveness of N-acetylcysteine (NAC) for the treatment of disease and its effect on physiological systems, other considerations of NAC are important, including the pharmacology, formulations, and adverse effects of NAC. This chapter will review these important aspects of NAC. Few published trials have examined the pharmacokinetics of NAC. Maximum plasma concentration increases with oral NAC doses (up to 1200 mg has been studied), particularly with sustained-release formulations. Oral and intravenous NAC seems to have similar half-lives (around 6 h). The pharmacokinetics of NAC is altered by chronic liver and renal disease as well as exercise. Clearance is altered in the neonatal period and with dialysis. NAC does not appear to alter the concentration of several common antibiotics, including amoxicillin, cefadroxil, cefpodoxime, doxycycline, and erythromycin. There are many nonprescription forms of NAC that are not regulated, particularly in the United States, which can easily oxidize in its dimeric form (“di-NAC”) which can result in opposite physiological effects. There are several formulations that follow Good Manufacturing Practice standards that are believed to be more stable." @default.
- W2890924006 created "2018-09-27" @default.
- W2890924006 creator A5010005336 @default.
- W2890924006 creator A5014638156 @default.
- W2890924006 creator A5021143842 @default.
- W2890924006 creator A5028344118 @default.
- W2890924006 creator A5034078008 @default.
- W2890924006 creator A5035904189 @default.
- W2890924006 creator A5038802341 @default.
- W2890924006 creator A5042546788 @default.
- W2890924006 creator A5043356624 @default.
- W2890924006 creator A5048484701 @default.
- W2890924006 creator A5049977155 @default.
- W2890924006 creator A5056940356 @default.
- W2890924006 creator A5062244050 @default.
- W2890924006 creator A5062904981 @default.
- W2890924006 creator A5064062205 @default.
- W2890924006 creator A5068674673 @default.
- W2890924006 creator A5072471685 @default.
- W2890924006 creator A5074496105 @default.
- W2890924006 creator A5075042924 @default.
- W2890924006 creator A5077240480 @default.
- W2890924006 creator A5077775452 @default.
- W2890924006 creator A5079550858 @default.
- W2890924006 creator A5085951307 @default.
- W2890924006 date "2018-09-21" @default.
- W2890924006 modified "2023-10-16" @default.
- W2890924006 title "Pharmacology, Formulations, and Adverse Effects" @default.
- W2890924006 cites W1879953056 @default.
- W2890924006 cites W1982499853 @default.
- W2890924006 cites W1982861271 @default.
- W2890924006 cites W1983144275 @default.
- W2890924006 cites W1993346574 @default.
- W2890924006 cites W1998688380 @default.
- W2890924006 cites W2000607917 @default.
- W2890924006 cites W2010889710 @default.
- W2890924006 cites W2011913092 @default.
- W2890924006 cites W2013480870 @default.
- W2890924006 cites W2018576561 @default.
- W2890924006 cites W2022148560 @default.
- W2890924006 cites W2035491511 @default.
- W2890924006 cites W2041162136 @default.
- W2890924006 cites W2053593008 @default.
- W2890924006 cites W2062290339 @default.
- W2890924006 cites W2062768591 @default.
- W2890924006 cites W2063228094 @default.
- W2890924006 cites W2064354000 @default.
- W2890924006 cites W2066351956 @default.
- W2890924006 cites W2068493248 @default.
- W2890924006 cites W2076153823 @default.
- W2890924006 cites W2092069111 @default.
- W2890924006 cites W2094321502 @default.
- W2890924006 cites W2095080951 @default.
- W2890924006 cites W2097653038 @default.
- W2890924006 cites W2127157208 @default.
- W2890924006 cites W2128506481 @default.
- W2890924006 cites W2132780391 @default.
- W2890924006 cites W2154031939 @default.
- W2890924006 cites W2156154257 @default.
- W2890924006 cites W2258852132 @default.
- W2890924006 cites W2322823240 @default.
- W2890924006 cites W2425389815 @default.
- W2890924006 cites W2767839334 @default.
- W2890924006 doi "https://doi.org/10.1007/978-981-10-5311-5_21" @default.
- W2890924006 hasPublicationYear "2018" @default.
- W2890924006 type Work @default.
- W2890924006 sameAs 2890924006 @default.
- W2890924006 citedByCount "0" @default.
- W2890924006 crossrefType "book-chapter" @default.
- W2890924006 hasAuthorship W2890924006A5010005336 @default.
- W2890924006 hasAuthorship W2890924006A5014638156 @default.
- W2890924006 hasAuthorship W2890924006A5021143842 @default.
- W2890924006 hasAuthorship W2890924006A5028344118 @default.
- W2890924006 hasAuthorship W2890924006A5034078008 @default.
- W2890924006 hasAuthorship W2890924006A5035904189 @default.
- W2890924006 hasAuthorship W2890924006A5038802341 @default.
- W2890924006 hasAuthorship W2890924006A5042546788 @default.
- W2890924006 hasAuthorship W2890924006A5043356624 @default.
- W2890924006 hasAuthorship W2890924006A5048484701 @default.
- W2890924006 hasAuthorship W2890924006A5049977155 @default.
- W2890924006 hasAuthorship W2890924006A5056940356 @default.
- W2890924006 hasAuthorship W2890924006A5062244050 @default.
- W2890924006 hasAuthorship W2890924006A5062904981 @default.
- W2890924006 hasAuthorship W2890924006A5064062205 @default.
- W2890924006 hasAuthorship W2890924006A5068674673 @default.
- W2890924006 hasAuthorship W2890924006A5072471685 @default.
- W2890924006 hasAuthorship W2890924006A5074496105 @default.
- W2890924006 hasAuthorship W2890924006A5075042924 @default.
- W2890924006 hasAuthorship W2890924006A5077240480 @default.
- W2890924006 hasAuthorship W2890924006A5077775452 @default.
- W2890924006 hasAuthorship W2890924006A5079550858 @default.
- W2890924006 hasAuthorship W2890924006A5085951307 @default.
- W2890924006 hasConcept C112705442 @default.
- W2890924006 hasConcept C185592680 @default.
- W2890924006 hasConcept C197934379 @default.
- W2890924006 hasConcept C2777056448 @default.
- W2890924006 hasConcept C2777179404 @default.
- W2890924006 hasConcept C2777847592 @default.
- W2890924006 hasConcept C2778004101 @default.
- W2890924006 hasConcept C2780131815 @default.